Harrow Health Inc (NASDAQ: HROW) stock closed at $11.60 on 5/10/24 after a major increase of 12.7%. Moreover, trading volume in this advance was exceptionally high at 231% of normal. The stock has risen 9.0% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
HROW is expected to be an important Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Harrow Health has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Harrow Health has a neutral Appreciation Score of 43 but a poor Power Rating of 19, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment